What is the recommended management for preterm premature rupture of membranes (PPROM)?

PPROM Management

For PPROM ≥24 weeks with expectant management, administer broad-spectrum antibiotics for 7-10 days and corticosteroids between 24-34 weeks; deliver at 34-37 weeks based on gestational age and clinical stability. 1, 2

Initial Assessment & Diagnosis

• Confirm diagnosis via sterile speculum examination showing pooling of amniotic fluid
• If equivocal, perform IGFBP-1 or PAMG-1 vaginal fluid test 2
• Obtain vaginal/rectal GBS swab
• Assess for chorioamnionitis using combination of: clinical signs, maternal CRP/WBC, and fetal heart rate patterns (never use single parameter alone) 2
• Ultrasound for amniotic fluid volume and fetal presentation

Gestational Age-Specific Management Algorithm

Previable/Periviable (<24 weeks)

• Counsel on both abortion care AND expectant management - all patients must be offered abortion care 1
• If expectant management chosen at 20-23+6 weeks: antibiotics can be considered (Grade 2C) 1
• At ≥24 weeks: antibiotics mandatory (Grade 1B) 1
• Do NOT give steroids or magnesium sulfate until neonatal resuscitation would be appropriate and desired 1

24-33+6 weeks (Viable Preterm)

• Antibiotics: 7-day regimen 1, 2

  • IV ampicillin + erythromycin × 48 hours
  • Then oral amoxicillin + erythromycin × 5 days
  • Alternative: Azithromycin if erythromycin unavailable 1
  • Avoid amoxicillin-clavulanate (increased necrotizing enterocolitis risk) 1
  • RCOG recommends erythromycin alone for 10 days or until labor 2

• Corticosteroids: Single course betamethasone or dexamethasone 2

  • Mandatory 24-33+6 weeks
  • Consider up to 35+6 weeks 2

• Magnesium sulfate: If delivery imminent within 24 hours at 24-29+6 weeks for neuroprotection 2

• Expectant management until 34-37 weeks unless contraindications develop 2

34-36+6 weeks (Late Preterm)

• Deliver at 34 weeks if stable 2
• Antibiotics and steroids per above if not previously given
• Timing individualized between 34-37 weeks based on clinical status 2

Contraindications to Expectant Management (Deliver Immediately)

• Clinical chorioamnionitis
• Fetal compromise
• Placental abruption
• Active labor
• Severe maternal illness

Special Circumstances

Cerclage in situ

• Either remove OR leave in place after shared decision-making discussion of risks/benefits 1
• No clear superiority of either approach 1

Investigational/NOT Recommended

• Serial amnioinfusions 1
• Amniopatch 1
• Both only in research settings (Grade 1B) 1

Monitoring During Expectant Management

• Inpatient vs outpatient: Guidelines traditionally recommend inpatient, though selected stable patients may be candidates for outpatient management after initial stabilization period
• Monitor for signs of infection, labor, fetal compromise
• Serial assessment of amniotic fluid volume
• Daily maternal temperature and symptoms

Subsequent Pregnancy Management

• Follow guidelines for previous spontaneous preterm birth 1
• Consider progesterone supplementation and cervical length surveillance per standard preterm birth prevention protocols

Critical Pitfalls to Avoid

⚠️ Never use amoxicillin-clavulanate - associated with neonatal NEC 1

⚠️ Do not diagnose chorioamnionitis on single parameter (e.g., isolated fever or elevated WBC) - requires combined clinical assessment 2

⚠️ Do not give steroids/magnesium in previable PPROM unless neonatal resuscitation planned and desired 1

⚠️ Must offer abortion care to all patients with previable/periviable PPROM - maternal mortality risk exists with no guarantee of fetal benefit 1

---

Key Evidence Note: The 2024 SMFM guidelines 1 represent the most recent high-quality evidence, endorsed by ACOG, and explicitly address the critical issue of maternal mortality risk in previable/periviable PPROM. The RCOG 2019 guidelines 2 provide complementary recommendations for viable gestations with Grade A evidence for antibiotic and steroid use.